Tag: Coalition for Healthcare Communication conference

Coalition for Healthcare Communication conference

Regulatory/FDA

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

July 22, 2019 – Social science research conducted at the FDA’s Office of Prescription Drug Promotion (OPDP) is designed to investigate issues relevant to healthcare professional and consumer use of medical product information, to consider the audience’s perception and comprehension of that information, and to assess the accuracy and effectiveness of promotional messaging, according to […]

Read more

CHC News

Kay Holcombe joins Rising Leaders Conference Faculty, Jim Davidson to Keynote

Kay Holcombe joins Rising Leaders Conference Faculty, Jim Davidson to Keynote

May 16, 2019 — Exactly how do laws get crafted or regulations finalized in Washington in the year 2019? Kay Holcombe—who has been an FDA official, a key staffer in both the Senate and the House, and Senior VP of BIO—will share her informed perspective on “how the sausage gets made” at this year’s Rising Leaders […]

Read more

Washington Focus

Bigelow: Divided Government Means Danger for Pharma in 2019

Bigelow: Divided Government Means Danger for Pharma in 2019

Jan. 7, 2019 – As the new members of Congress get to work in a now-divided government, the healthcare communications industry needs to remain engaged and vigilant, warns Coalition for Healthcare Communication Executive Director Jon Bigelow. Although Wall Street seems to think that a divided government – with the House and Senate controlled by different […]

Read more

General

Top 10 Compliance Tips for Healthcare Communications Companies

Top 10 Compliance Tips for Healthcare Communications Companies

Jan. 3, 2019 – As healthcare communicators start off 2019, keeping an eye on the best ways to remain compliant is now a bit easier thanks to James N. Czaban, chair of the FDA and Medical Products Regulatory Practice at DLA Piper LLP in Washington, D.C. Speaking at the Coalition for Healthcare Communication’s Post-election Conference […]

Read more

DTC Advertising

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

Dec. 17, 2018 – The Coalition for Healthcare Communication (CHC) finds the recent proposal to require drug list prices in direct-to-consumer (DTC) television ads “detrimental to the interests of both health providers and patients,” and raises numerous practical and legal concerns to support that position in its official comment filed Dec. 14 with the Centers […]

Read more

Washington Focus

Midterms Delivered Divided Government, New Players

Midterms Delivered Divided Government, New Players

Nov. 30, 2018 – The 2018 midterm elections resulted in a divided Congress, questions about possible agency changes, and uncertainty related to drug pricing policy and the Affordable Care Act, according to Kate Rawson, senior editor, Prevision Policy and The RPM Report, who spoke at the Coalition for Healthcare Communication’s “2018 Post-election Conference on Healthcare […]

Read more